Position in FLGT
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$488,232
New position
Shares Held
23,793
first reported quarter
Ownership
0.086%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#69
of 142 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Persistent Asset Partners Ltd holds $2,945,156 across 8 Diagnostics & Research names. FLGT ranks #4 (16.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
4,275 | $641,377 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,235 | $619,179 | |
| 3 | WGS |
GeneDx Holdings Corp.
|
8,555 | $587,300 | |
| 4 | FLGT |
Fulgent Genetics, Inc.
This page
|
23,793 | $488,232 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
1,177 | $266,931 | |
| 6 | ICLR |
Icon PLC
|
1,431 | $248,579 | |
| 7 | DGX |
Quest Diagnostics Inc
|
429 | $90,926 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
5 | $2,632 |
All Filings in FLGT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $488,232 | 23,793 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||